Calgary, Canada

Scott Gray-Owen


Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1998-2006

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Scott Gray-Owen: Innovator in Transferrin Receptor Research

Introduction

Scott Gray-Owen is a prominent inventor based in Calgary, Canada. He has made significant contributions to the field of medical research, particularly in the area of transferrin receptor genes. With a total of 10 patents to his name, Gray-Owen's work has implications for diagnostics and medical treatments.

Latest Patents

Gray-Owen's latest patents focus on purified and isolated nucleic acids that encode transferrin receptor proteins. These innovations include methods for producing peptides that are free of contaminants derived from bacteria, which are essential for diagnostics and medical treatment. His patents also encompass recombinant Tbp1 and Tbp2 proteins, along with methods for their purification. Additionally, he has developed live vectors that express epitopes of transferrin receptor proteins for vaccination purposes.

Career Highlights

Throughout his career, Scott Gray-Owen has worked with notable companies such as Connaught Laboratories Limited and Aventis Pasteur Limited. His experience in these organizations has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Some of his notable coworkers include Sheena M Loosmore and Robin E Harkness. Their collaborative efforts have further enriched the research environment in which Gray-Owen operates.

Conclusion

Scott Gray-Owen's innovative work in transferrin receptor research has positioned him as a key figure in the field. His patents and collaborations continue to influence medical diagnostics and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…